Mental Health Management Group

Mental Health Management Group Child, Adolescent & Adult Psychiatry

Serving the mental health needs of Tampa Bay, Florida. Located in Brandon 5 minutes from the Crosstown Causeway

Start with a 15 minute consultation. No commitment required. Consultation helps determine if ExoMind® may be appropriate...
05/28/2026

Start with a 15 minute consultation. No commitment required. Consultation helps determine if ExoMind® may be appropriate for you. Local Care. Advanced Solutions. (813) 657-7022
https://mhmgroup.com/exomind-consultation

Can Stress Cause Depression and Anxiety? The Long and Short Answers
05/28/2026

Can Stress Cause Depression and Anxiety? The Long and Short Answers

Learn how chronic stress may contribute to depression and anxiety. Explore the biological links, symptoms, and available treatment options.

Clear information and careful clinical evaluation are essential when discussing stimulant medication. When ADHD is accur...
05/21/2026

Clear information and careful clinical evaluation are essential when discussing stimulant medication. When ADHD is accurately diagnosed, stimulant medication is not intended to sedate or suppress personality. The goal is symptom management. Response varies by individual, and careful monitoring is required.

How it’s misused - tip: If you don’t have ADHD, it speeds you up. Concerns surrounding stimulant medications often relate to misuse.

Learn more here:

A balanced overview of Adderall, generic stimulants, and how ADHD medication decisions are made.

05/20/2026

Mental Health Management Group and Dr. Noonan continue to explore innovative, non-invasive treatment technologies in psychiatric care. ExoMind® neuromodulation therapy consultations are now available for individuals interested in learning whether this approach may be appropriate for their needs. Individuals interested in learning more may request a consultation by clicking here:
https://mhmgroup.com/exomind-consultation/?source=facebook

05/19/2026

Reading between the lines. More info on MeRT.

From what I’m reading, the primary distinction being promoted is “personalization” through EEG brain mapping and individualized coil placement. However, personalization has long been part of quality magnetic treatment. At MHM Group, both of our magnetic therapy systems, NeuroStar and Exomind, involve individualized treatment planning based on a patient’s diagnosis, symptoms, treatment history, goals, and physician evaluation.

Placement and protocol selection are also not “one size fits all.” These decisions are made while the patient and treating clinician are actively in the office together, determining the most appropriate treatment approach.

Interestingly, even several MeRT-focused websites describe MeRT as essentially a more customized application of TMS using EEG/qEEG guidance rather than a completely separate technology.

As magnetic therapy continues evolving, I suspect we’ll continue to see more branding language emerge around personalization, precision, and brain mapping. The important question for patients is likely less about the marketing terminology and more about the quality of the clinical evaluation, physician oversight, safety, and whether treatment is thoughtfully individualized to the person sitting in the chair.

Information on medication tapering.  Depression is still enormously prevalent. It is the leading cause of disability in ...
05/11/2026

Information on medication tapering. Depression is still enormously prevalent. It is the leading cause of disability in the world. Most people with depression do not get properly identified, diagnosed, and treated. Some statistics would say less than 1 in 5 people with depression is getting even minimally appropriate care. Additionally, our medicines are not as dramatically helpful as we wish they were in getting rid of symptoms. There is about maybe a 40% chance of a good success with a first go on an antidepressant, and then maybe a 25% to 30% chance of success with a second. A sizable number of people who struggle with depression may not derive enough benefit from a medicine, even when it is adequately dosed and taken. This is a real dilemma, because the remedy here is not to say, ‘let's just do away with medicines and stop them’. It is important to taper off of medication because there can be side effects of going "going turkey".

Additionally, as providers, we keep in mind patients’ unique circumstances; their candidacy for appropriate, evidence-based treatments, whether those are pharmacologic, psychotherapeutic, or device based, such as brain stimulation neuromodulation approaches, interventional psychiatry approaches, ketamine, transcranial magnetic stimulation; and aligning the right treatment with the right patient.

This information is provided by the Psychiatric Times. Link here to read more on progress of psychopharmacology.

If you are on an antidepressant or anxiety medications, please seek assitance with a licensed mental health psychiatrist, experienced in tapering off medication. We are here to help.

HHS targets psychiatric overprescribing; expert Joseph F. Goldberg, MD, urges careful deprescribing—stop ineffective medications and replace with evidence-based treatments.

The question is no longer simply whether cannabis should be legal. It is whether legalization has encouraged a more dang...
05/09/2026

The question is no longer simply whether cannabis should be legal. It is whether legalization has encouraged a more dangerous assumption: that cannabis is safe because its use is legal, or harmless enough to normalize. Some patients present with paranoia, panic, mood instability, perceptual disturbance, or a first psychotic break. Many are young. Many are using increasingly potent cannabis products. As legalization expands, clinicians are increasingly asked to manage a widening gap between public perception and psychiatric risk. Read more from the Psychiatric Times Study.

New cohort and global data link teen high-potency cannabis use to higher psychosis, bipolar, and su***de risks. Here's what psychiatrists and mental health clinicians should know in the era of legalization.

05/05/2026

What is Exomind? Dr Noonan offers ExoMind® as a non-invasive neuromodulation service that may be considered within a structured psychiatric care plan. ExoMind is a neuromodulation device that delivers targeted electromagnetic stimulation to specific regions of the brain involved in mood and cognitive regulation.

https://mhmgroup.com/services/exomind-therapy/

Address

1119 Nikki View Drive
Brandon, FL
33511

Opening Hours

Monday 9am - 7pm
Tuesday 8:30am - 7pm
Wednesday 8:30am - 7pm
Thursday 8:30am - 7pm

Telephone

+18136577022

Alerts

Be the first to know and let us send you an email when Mental Health Management Group posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Mental Health Management Group:

Share

Category